A potential malaria vaccine produced by genetically-engineered algae could allow people to grow their own vaccine at homes, and would be especially useful in rural parts of the developing world, say its developers. The...
It is difficult to overstate how much the fight against infectious diseases has improved the human condition in the last century. In research released today, for Copenhagen Consensus 2012, economists Dean Jamison...
Genocea Biosciences recently announced that it will highlight the development of a new malaria vaccine at an upcoming presentation at the World Vaccine Congress. Dr. Jessica Baker Fletcher, Genocea’s vice president of...
Dividing her days between treating malaria in Kenya’s coastal regions and administering the latest malaria vaccine prototype, Dr. Patricia Njuguna has high hopes for preventing a disease that annually claims more...
Malaria mortality rates have fallen by more than 25% globally since 2000, and by 33% in the WHO African Region, according to the World Malaria Report 2011, issued by the World Health Organization.🔒 Premium Content - For...
Polio eradication was a hot topic at the 38th Session of the Council of Foreign Ministers of the newly renamed Organisation of Islamic Cooperation🔒 Premium Content - For FreeUnlock this content by becoming a Global...
A malaria vaccine to protect against all known strains of the deadly disease is being launched by Griffith University’s Institute for Glycomics.🔒 Premium Content - For FreeUnlock this content by becoming a Global...
A new analysis of progress in the global fight against malaria has found a four-fold increase in annual funding for malaria research and development (R&D) in just 16 years🔒 Premium Content - For FreeUnlock this...
A new study uncovers a powerful strategy for eliciting an immune response that can combat the parasite during multiple stages of its complex life cycle🔒 Premium Content - For FreeUnlock this content by becoming a Global...
The RTS,S Malaria vaccine, developed by pharmaceutical company GlaxoSmithKline (GSK) and PATH Malaria Vaccine Initiative (MVI), began its third clinical trial in Africa today.🔒 Premium Content - For FreeUnlock this...